Vol 6, No 3 (2017)
Review article
Published online: 2017-09-29
Diabetic enteropathy — still undefeated?
DOI: 10.5603/DK.2017.0017
Clin Diabetol 2017;6(3):105-110.
Abstract
Diabetic enteropathy is a specific diabetic complication. It could be presented as constipations, diarrhoea or faecal incontinence. The aetiology is multifactorial. The main role is attributed to irreversible autonomic neuropathy, which often coexists with peripheral sensorimotor neuropathy. Nowadays, enteropathy is diagnosed after exclusion of other causes, like coeliac disease, hypo- or hyperthyroidism, inflammatory bowel disease, small intestinal bacterial overgrowth, exocrine pancreatic insufficiency and adverse drug reaction. The article presents new reports about enteropathy reversibility after simultaneous pancreas-kidney transplantation in patients with abnormal levels of IGF-1 and IGFBP3. It provides new data on pathogenesis of enteropathy and presents new diagnostic and therapeutic approaches. (Clin Diabetol 2017; 6, 3: 105–110)
Keywords: diabetesdiabetic enteropathydiabetic autonomic neuropathydiabetic diarrhoeafaecal incontinence
References
- Chandrasekharan B, Anitha M, Blatt R, et al. Colonic motor dysfunction in human diabetes is associated with enteric neuronal loss and increased oxidative stress. Neurogastroenterol Motil. 2011; 23(2): 131–138.
- Mashimo H, May RJ, Goyal RK. Joslin's diabetes mellitus. Lippincott Williams & Wilkins, Boston, 2005: 1069–1098.
- Lysy J, Israeli E, Goldin E. The prevalence of chronic diarrhea among diabetic patients. Am J Gastroenterol. 1999; 94(8): 2165–2170.
- Bytzer P, Talley NJ, Leemon M, et al. Prevalence of gastrointestinal symptoms associated with diabetes mellitus: a population-based survey of 15,000 adults. Arch Intern Med. 2001; 161(16): 1989–1996.
- Østergaard L, Finnerup NB, Terkelsen AJ, et al. The effects of capillary dysfunction on oxygen and glucose extraction in diabetic neuropathy. Diabetologia. 2015; 58(4): 666–677.
- Chung SSM, Ho ECM, Lam KSL, et al. Contribution of polyol pathway to diabetes-induced oxidative stress. J Am Soc Nephrol. 2003; 14(8 Suppl 3): S233–S236.
- Goldin A, Beckman JA, Schmidt AM, et al. Advanced glycation end products: sparking the development of diabetic vascular injury. Circulation. 2006; 114(6): 597–605.
- Koya D, King GL. Protein kinase C activation and the development of diabetic complications. Diabetes. 1998; 47(6): 859–866.
- Bytzer P, Talley NJ, Hammer J, et al. GI symptoms in diabetes mellitus are associated with both poor glycemic control and diabetic complications. Am J Gastroenterol. 2002; 97(3): 604–611.
- D'Addio F, La Rosa S, Maestroni A, et al. Circulating IGF-I and IGFBP3 Levels Control Human Colonic Stem Cell Function and Are Disrupted in Diabetic Enteropathy. Cell Stem Cell. 2015; 17(4): 486–498.
- Tafil-Klawe M, Klawe JJ. Wykłady z fizjologii człowieka. PZWL, Warszawa 2010: 960–990.
- Dooley CP, el Newihi HM, Zeidler A, et al. Abnormalities of the migrating motor complex in diabetics with autonomic neuropathy and diarrhea. Scand J Gastroenterol. 1988; 23(2): 217–223.
- Adamska A, Nowak M, Piłaciński S, et al. Częstość występowania zespołu rozrostu bakteryjnego jelita cienkiego (SIBO) u pacjentów z cukrzycą. Clinical Diabetology. 2015; 4(5): 175–182.
- Aitchison M, Fisher BM, Carter K, et al. Impaired anal sensation and early diabetic faecal incontinence. Diabet Med. 1991; 8(10): 960–963.
- Husby S, Koletzko S, Korponay-Szabó IR, et al. ESPGHAN Working Group on Coeliac Disease Diagnosis, ESPGHAN Gastroenterology Committee, European Society for Pediatric Gastroenterology, Hepatology, and Nutrition. European Society for Pediatric Gastroenterology, Hepatology, and Nutrition guidelines for the diagnosis of coeliac disease. J Pediatr Gastroenterol Nutr. 2012; 54(1): 136–160.
- Brock C, Brock B, Pedersen AG, et al. Assessment of the cardiovascular and gastrointestinal autonomic complications of diabetes. World J Diabetes. 2016; 7(16): 321–332.
- Farmer AD, Scott SM, Hobson AR. Gastrointestinal motility revisited: The wireless motility capsule. United European Gastroenterol J. 2013; 1(6): 413–421.
- Krishnan B, Babu S, Walker J, et al. Gastrointestinal complications of diabetes mellitus. World J Diabetes. 2013; 4(3): 51–63.
- Bharucha AE, Low P, Camilleri M, et al. A randomised controlled study of the effect of cholinesterase inhibition on colon function in patients with diabetes mellitus and constipation. Gut. 2013; 62(5): 708–715.
- Wald A, Tunuguntla AK. Anorectal sensorimotor dysfunction in fecal incontinence and diabetes mellitus. Modification with biofeedback therapy. N Engl J Med. 1984; 310(20): 1282–1287.
- Herman RM, Wałęga P. Widera A; Biofeedback jako zachowawcza metoda leczenia nietrzymania stolca. Przegl Lek. 2004; 61: 54–59.
- Herman RM, Wałęga P, Nowakowski M, et al. Transanal electrostimulation in the treatment of fecal incontinence following low anterior rectum resection. International Proceedings Division. 2001: 295–299.
- Sugrue J, Lehur PA, Madoff RD, et al. Long-term Experience of Magnetic Anal Sphincter Augmentation in Patients With Fecal Incontinence. Dis Colon Rectum. 2017; 60(1): 87–95.
- Karnafel W, Mrozikiewicz-Rakowska B. Zespół stopy cukrzycowej. Termedia, Poznań 2010: 34.